J 2023

Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study

CHRASTINA, Jan, Ondřej HORÁK, Michal RYZÍ, Milan BRÁZDIL, Zdeněk NOVÁK et. al.

Basic information

Original name

Single-center long-term results of vagus nerve stimulation for pediatric epilepsy: a 10-17-year follow-up study

Authors

CHRASTINA, Jan (203 Czech Republic, guarantor, belonging to the institution), Ondřej HORÁK (203 Czech Republic, belonging to the institution), Michal RYZÍ (203 Czech Republic, belonging to the institution), Milan BRÁZDIL (203 Czech Republic, belonging to the institution), Zdeněk NOVÁK (203 Czech Republic, belonging to the institution), Tomáš ZEMAN (203 Czech Republic, belonging to the institution) and Pavlína DANHOFER (203 Czech Republic, belonging to the institution)

Edition

Childs nervous system, NEW YORK, SPRINGER, 2023, 0256-7040

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.400 in 2022

RIV identification code

RIV/00216224:14110/23:00134637

Organization unit

Faculty of Medicine

UT WoS

000992036000001

Keywords in English

Seizure; Stimulation treatment; Stimulation responder; Palliative surgery

Tags

International impact, Reviewed
Změněno: 14/2/2024 19:56, Mgr. Eva Dubská

Abstract

V originále

PurposeA retrospective study, based on a prospectively built database, presents the results of long-term follow-up care of pediatric vagus nerve stimulation (VNS) patients in terms of seizure outcome, surgical aspects, the potential impact of maturation, and medication changes.MethodsFrom a prospectively built database, 16 VNS patients (median age 12.0 years, range 6.0 to 16.0 years; median seizure duration 6.5 years, range 2.0 to 15.5 years) followed for at least 10 years were graded as non-responder - NR (seizure frequency reduction < 50%), responder - R (reduction >= 50% and < 80%), and 80% responder - 80R (reduction >= 80%). Data about surgical aspects (battery replacement, system complications), seizure dynamics, and medication changes were taken from the database.ResultsThe early percentages of good results (80R + R) were 43.8% (year 1), 50.0% (year 2), and 43.8% (year 3). These percentages remained stable between years 10 and 12 (50% year 10; 46.7% year 11; 50% year 12) and increased in years 16 (60%) and 17 (75%). Depleted batteries were replaced in ten patients, six of whom were either R or 80R. In the four NR, the indication for replacement was improved quality of life. Three patients had VNS explanted or switched off-one had repeated asystolia and two were NR. The effect of hormonal changes in menarche on seizure was not proven. During the study, antiseizure medication was changed in all patients.ConclusionsThe study proved the efficacy and safety of VNS in pediatric patients over an exceptionally long follow-up period. The demand for battery replacements indicates a positive treatment effect.

Links

NV19-04-00343, research and development project
Name: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Acronym: PRESEnCE)
Investor: Ministry of Health of the CR